HAVCR2 and neoplasm: Researchers found that TIM-3 on DCs but not on CD4+ or CD8 + T cells has singular function to restrain anti-tumor immunity through impeding the maintenance of effector T cells and stem-like CD8 + T cells, resulting in inhibition of protective immune effects and reduction of NLRP3 inflammasome activation [104].